Skip to Content

Two drugs for hepatitis C, Harvoni and Sovaldi, helped sales top $7 billion during the final quarter of 2014 for this biopharma company.

Company Information

Location
Foster City, CA
Industry
Pharmaceuticals
Sector
Health Care
Fortune 500 Rank118
Fortune 500 Profilehttp://fortune.com/fortune500/gilead-sciences-118/
Current Streak1
Years on List6
CEO
John C. Martin
Websitehttp://www.gilead.com

Revenue, Net Income

Revenue Past Four Quarters27,485
Net Income Past Four Quarters14,207

Growth Rates

EPS 3 yr Annual Growth Rate67%
Rev 3 yr Annual Growth Rate43%
Total Return 3 yr Annual Rate66%
Beat S&P 3 yr Total Return?
yes

Rank

EPS Growth Rank32
Revenue Growth Rank21
Total Return Rank
21